ZEISS Insights: Technical paper on the QA of Armbruster's hybrid manufacturing approach

Additive manufacturing is becoming increasingly important in the field of complex medical implant and instrument applications. In direct comparison with subtractive manufacturing, one of the main reasons for this is the increasing need for a high degree of design freedom, often coupled with patient-specific features, which in many medical applications can no longer be achieved with conventional manufacturing technologies alone.

Armbruster GmbH's hybrid manufacturing process for trial implants combines additive and subtractive methods. ZEISS offers efficient and holistic quality assurance solutions from the raw material to the finished medical device.